- Home
- PAR vs NVCR Comparison
PAR vs NVCR Comparison
Compare PAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- NVCR
- Stock Information
- Founded
- PAR 1968
- NVCR 2000
- Country
- PAR United States
- NVCR Jersey
- Employees
- PAR N/A
- NVCR N/A
- Industry
- PAR Office Equipment/Supplies/Services
- NVCR Medical/Dental Instruments
- Sector
- PAR Miscellaneous
- NVCR Health Care
- Exchange
- PAR Nasdaq
- NVCR Nasdaq
- Market Cap
- PAR 2.8B
- NVCR 3.2B
- IPO Year
- PAR N/A
- NVCR 2015
- Fundamental
- Price
- PAR $71.53
- NVCR $29.99
- Analyst Decision
- PAR Strong Buy
- NVCR Buy
- Analyst Count
- PAR 8
- NVCR 5
- Target Price
- PAR $79.25
- NVCR $33.40
- AVG Volume (30 Days)
- PAR 361.9K
- NVCR 1.1M
- Earning Date
- PAR 02-25-2025
- NVCR 02-20-2025
- Dividend Yield
- PAR N/A
- NVCR N/A
- EPS Growth
- PAR N/A
- NVCR N/A
- EPS
- PAR N/A
- NVCR N/A
- Revenue
- PAR $453,986,000.00
- NVCR $577,738,000.00
- Revenue This Year
- PAR N/A
- NVCR $19.13
- Revenue Next Year
- PAR $19.03
- NVCR $5.38
- P/E Ratio
- PAR N/A
- NVCR N/A
- Revenue Growth
- PAR 49.11
- NVCR 14.63
- 52 Week Low
- PAR $37.74
- NVCR $11.70
- 52 Week High
- PAR $82.24
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- PAR 40.00
- NVCR 58.14
- Support Level
- PAR $71.59
- NVCR $29.62
- Resistance Level
- PAR $75.47
- NVCR $32.06
- Average True Range (ATR)
- PAR 2.66
- NVCR 1.80
- MACD
- PAR -0.94
- NVCR -0.60
- Stochastic Oscillator
- PAR 4.41
- NVCR 8.20
About PAR PAR Technology Corporation
PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.